Facing declining core automotive revenue, Tesla announces a radical strategic shift, halting production of flagship luxury models to fund a massive push into robotics and autonomous vehicles. Investors are left weighing ambitious promises against a backdrop of financial strain.
Ripple has released 1 billion XRP from escrow as part of its monthly supply management plan, while the token's price continues to slide in a weak broader crypto market.
Blockchain security firm CertiK reports a dramatic spike in cryptocurrency thefts for January 2026, with losses hitting $370.3 million—the highest monthly figure in 11 months. The surge is driven by a mix of sophisticated social engineering attacks and persistent on-chain exploits, highlighting the evolving threats facing the digital asset space.
As the war in Ukraine grinds on and U.S. support appears to waver, a nuanced public debate over Gaza is emerging in Kyiv, challenging earlier unequivocal backing for Israel and revealing complex parallels in perceived injustice.
RATIONAL AG's stock has seen a notable 12% climb on the XTRA exchange in recent months, reigniting investor debate. Our analysis suggests the shares may now be overvalued, trading above intrinsic value. We examine the outlook, growth potential, and whether investors should wait for a better entry point.
As the EU's landmark 'Next Generation' fund nears its final payout deadlines, its ambitious goal of modernizing the bloc's economy is being hampered by bureaucracy, skills gaps, and questions over long-term sustainability, despite pockets of innovation.
TransDigm Group's recent acquisitions of Stellant Systems and Jet Parts Engineering, totaling over $3 billion, have analysts debating whether the moves solidify its lucrative aftermarket strategy or stretch its leveraged balance sheet too thin ahead of a critical earnings season.
The FDA has cleared Intuitive Surgical's latest robotic system for use in certain heart surgeries, marking a strategic expansion into one of healthcare's largest and most complex service lines and potentially reshaping hospital capital planning for robotics.
Glaukos Corporation secures a significant FDA nod allowing repeated administration of its sustained-release iDose TR implant, broadening treatment options for patients with glaucoma and potentially reshaping long-term care paradigms.
Shares of electrical connection specialist nVent Electric have surged nearly 80% in the past year, prompting investors to question whether the rally has outpaced the company's fundamental value. A deep dive into valuation metrics suggests caution may be warranted.
A fresh price target for Euronext Brussels-listed IT services firm Econocom Group has analysts and investors reassessing the company's trajectory. The update reflects evolving views on the company's strategic positioning and market conditions.
Nepali authorities have arrested six executives from travel and rescue companies, alleging a sophisticated fraud scheme involving fabricated high-altitude rescues to bilk international insurers out of nearly $20 million.
A Russian drone attack on a bus carrying Ukrainian miners home from work has left at least 12 dead and 8 wounded, officials say, in what is being condemned as a deliberate strike on civilians.
Citing weak network usage and a need to strengthen its economic model, the IP-centric blockchain Story Protocol has pushed back its major token supply unlock by six months to August 2026, aiming to mitigate sell-off risks and buy time for growth.
As markets look ahead to 2026, a mix of established giants and emerging players in AI and digital advertising present compelling opportunities for investors seeking both growth and value.
Amid broader market uncertainty, companies with high insider ownership and robust earnings forecasts can signal aligned interests and resilience. We examine three such UK-listed firms, from a gold miner to a convenience food giant, where those running the show have significant personal stakes.
Snapchat has disabled hundreds of thousands of accounts belonging to users under 16 in Australia under new social media laws, but warns the legislation contains 'significant gaps' that may allow some minors to bypass protections.
Cardiac monitoring specialist iRhythm has finalized a significant corporate restructuring, creating a new parent company to serve as its publicly listed entity on Nasdaq. The move is seen as a strategic step to streamline governance and provide operational flexibility as the company expands its AI-driven health platform.
Shares of insulin pump maker Tandem Diabetes Care have plummeted over 80% in five years, trading near $20. A deep dive into valuation metrics suggests the stock may now be modestly undervalued, but significant risks and competitive pressures remain.
Shares of Advantest Corp. have surged nearly 200% in the past year, riding the AI and advanced chipmaking wave. As the stock trades near record highs, investors are grappling with a critical question: has the rally run too far, too fast?
